Session 3: How to ensure the long-term future of advanced therapies for rare, ultra-rare and nano-rare diseases?
19 Jan 2027
Theatre 4
Commercializing Advanced Therapies
Topic
Clinical Development & Regulatory Strategy,Commercialisation & Market Access,Manufacturing CMC & Supply Chain,Patient Access Equity & Advocacy
Persona
Academic & Clinical Researchers,Biotech,Clinicians,Patient Advocates & Organizations,Payers,Pharma,Service Providers (CDMOs CROs & Suppliers)